Robot that removes cancer tumours without incisions gets $20.5 mil funding

Professor Lawrence Ho Khek Yu

Robot that removes cancer tumours without incisions gets $20.5 mil funding

By: 
Jude Chan
16/03/17, 04:46 pm

SINGAPORE (March 16): Local medical robotics firm EndoMaster announced Thursday that it raised $20.5 million in March – one of the largest sums for Series B funding for medical technology companies in Singapore.

EndoMaster’s robotic-assisted surgical system is able to remove gastro-intestinal cancer tumours without the need for surgical incisions on the body or organ.

According to EndoMaster, gastro-intestinal cancer is diagnosed in over three million people worldwide and causes more than two million deaths every year.

Advertisement

Current treatments to remove gastro-intestinal tumours require incisions on the abdomen and cutting out the affected sections of the stomach, colon or rectum.

A spin-off by Nanyang Technological University (NTU) and National University of Singapore (NUS), EndoMaster’s non-invasive tumour-removal lowers surgery time to less than one hour.

“The EndoMaster system was designed to enable complicated surgeries to be performed using existing openings like the mouth and anus, without requiring additional surgical access points,” says EndoMaster co-founder Louis Phee.

“In the future, we aim to perform more ‘no-hole’ surgeries on other major organs. The cost and medical benefits are apparent,” Phee adds.

EndoMaster says it is targeting the fast-growing global medical robotics market. The market is growing at a compound annual growth rate of 21.1%, and expected to more than double to US$12.8 billion by 2021.

“The new funds will enable EndoMaster to scale up this disruptive innovation, making endoscopic surgery easy, safe, and accessible to many more doctors in this world,” says EndoMaster co-founder Lawrence Ho.

EndoMaster says it is looking to launch its product in Europe in late 2018. It aims to surpass $100 million in revenue within five years of its product launch.

To find out more about the Master and Slave Transluminal Endoscopic Robot (MASTER), which was featured in The Edge Singapore in March 2014, click to read: Medical marvel.

Sysma awarded $5 mil construction contract by deputy CEO

SINGAPORE (Jan 16): Sysma Holdings’ wholly-owned subsidiary Sysma Construction has been awarded a $5 million contract for the construction of two two-storey detached houses at Medway Drive in Serangoon Gardens. The contract was awarded by Sin Ee Wuen, Sysma’s deputy chief executive officer, and the son of Sysma’s executive chairman and group CEO, Sin Soon Teng. As such, the deal constitutes an interested person transaction. Sin had appointed Ernesto Bedmar Architects as the consultant for the project. The architectural firm had issued the letter of acceptance of tender to Sysma ....
Read More >>

Slower economy, oversupply push Singapore's rental prices down for expats

(Jan 16): Hong Kong retained its title as Asia’s most expensive rental city for expatriates, while Singapore fell further down the ranking due to a slower economy and fewer relocations, according to consultancy firm ECA International. Hong Kong sat atop the list with an average price of $10,461 per month for an unfurnished, three-bedroom apartment in expatriate neighborhoods, according to results from ECA’s September 2017 accommodation survey. Tokyo held onto the No. 2 spot. Singapore slipped one spot to eighth. “This is due to a slowing of economic growth and a net reduction in in....
Read More >>

UMS Holdings acquires 7.48% stake in JEP Holdings for $5.7 mil

SINGAPORE (Jan 16): UMS Holdings, the precision engineering company, today announced that it has acquired a 7.48% stake or 109 million ordinary shares in JEP Holding for $5.7 million. The shares were acquired through the open market. The group satisfied the consideration in cash, funded through internal resources. Shares in UMS Holdings closed flat at $1.04 on Tuesday, while shares in JEP Holdings closed 0.1 cent lower at 6 cents. ....
Read More >>